An interventional study of electronic alert and clinical decision support system in Acute Kidney Injury, sponsored by Seattle Children's Hospital. Completed at 1 site in United States. Open to participants aged 6 Months to 18 Years. Per ClinicalTrials.gov, last updated 2019-04-04.
Sponsored by Seattle Children's Hospital · Not applicable, Interventional, and Supportive care
Acute kidney injury (AKI) is a common clinical event with severe consequences. In the United States alone, greater than one million hospitalized patients per year are diagnosed with AKI. It has been independently associated with prolonged hospital stays, 25-80% risk of in-hospital death, and future progression to chronic kidney disease. While there has been an increase in awareness about the prevalence and significance of AKI, studies have uncovered systematic failure in the management of AKI, largely relating to the failure of clinicians to recognize and manage the condition appropriately. This is where we can use electronic health records (EHRs) and electronic alerts (e-alerts) to our advantage. In this study, the investigators plan to use e-alerts integrated into a clinical decision support (CDS) system to improve the care of and outcomes of patients with AKI. The aims are to study the prevalence of AKI and its progression among hospitalized patients using an 'AKI sniffer' (an EHR based automated system) and to prospectively study if introducing a complex intervention (an e-alert combined with a clinical decision support system) will reduce progression of AKI in children. The investigators have developed an AKI care bundle which provides simple guidelines for management of AKI along with specific discharge instructions to improve follow up care. The primary outcome is AKI progression. Secondary outcomes include morbidity, mortality, length of hospital stay, need for renal replacement therapy, and recovery of renal function by time of hospital discharge. The investigators will also look at documentation of AKI and if these participants get appropriate follow up.
1,595 studies on the registry are indexed under Acute Kidney Injury; 371 are open to participants now.
This study's enrollment of 240 is above the median of 100 across 763 interventional studies indexed under Acute Kidney Injury.
Browse Acute Kidney Injury studies →Seattle Children's Hospital is the lead sponsor of 210 studies on the registry; 43 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients between 6 months-18 years admitted to the surgical and medical floors of Seattle Children's Hospital
Exclusion Criteria:
This will be the pre and post alert phase where e-alerts will not be sent to providers
This will be the phase when e-alerts will be sent to the provider
Other: electronic alert and clinical decision support system
Providers taking care of patients will receive an electronic alert and will be guided to use a clinical decision support system
AKI documentation
Documentation of AKI in progress notes and discharge summary
Time frame: 28 days
AKI progression
Progression of AKI from Stage 1 to Stage 2/3
Time frame: 7 days
Plan to share: No
This study is completed, as verified in Apr 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seattle Children's Hospital